New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma

Autor: Parareda A, Villaescusa JC, Sanchez de Toledo J, Gallego S

Publikováno v: NEUROSCIENCE LETTERS
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

Expression of Tyrosine Hydroxylase (TH) is frequently seen in neuroblastomas, the most common extracranial tumor in children, and TH mRNA detection is used for the analysis of microcirculating or micrometastatic disease in this neoplasia. TH is known

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2751231b2f75d30604c65badf8f5d83e
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7455

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinically compliant cryopreservation of differentiated retinal pigment epithelial cells.

Autor: Baqué-Vidal L; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Main H; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Petrus-Reurer S; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden; Department of Surgery, University of Cambridge, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Lederer AR; Laboratory of Neurodevelopmental Systems Biology, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland., Beri NE; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Bär F; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Metzger H; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Zhao C; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Efstathopoulos P; Cell Therapy R&D, Novo Nordisk A/S, Måløv, Denmark., Saietz S; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Wrona A; Cell Therapy R&D, Novo Nordisk A/S, Måløv, Denmark., Jaberi E; Cell Therapy R&D, Novo Nordisk A/S, Måløv, Denmark., Willenbrock H; Cell Therapy R&D, Novo Nordisk A/S, Måløv, Denmark., Reilly H; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Hedenskog M; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Moussaud-Lamodière E; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden., Kvanta A; Department of Clinical Neuroscience, Division of Eye and Vision, St. Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden., Villaescusa JC; Cell Therapy R&D, Novo Nordisk A/S, Måløv, Denmark., La Manno G; Laboratory of Neurodevelopmental Systems Biology, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland., Lanner F; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Division of Obstetrics and Gynecology, Karolinska Universitetssjukhuset, Stockholm, Sweden; Ming Wai Lau Center for Reparative Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Fredrik.lanner@ki.se.

Publikováno v: Cytotherapy [Cytotherapy] 2024 Apr; Vol. 26 (4), pp. 340-350. Date of Electronic Publication: 2024 Feb 13.

NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.

Autor: Torz L; In Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark.; Section for Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark., Niss K; Bioinformatics & Data Mining, Novo Nordisk, 2760 Måløv, Denmark., Lundh S; Pathology & Imaging, Novo Nordisk, 2760 Måløv, Denmark., Rekling JC; Department of Neuroscience, University of Copenhagen, 2200 Copenhagen, Denmark., Quintana CD; Cell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark., Frazier SED; Cell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark., Mercer AJ; Target Discovery Platforms, Novo Nordisk, Seattle, WA 98109, USA., Cornea A; Target Discovery Platforms, Novo Nordisk, Seattle, WA 98109, USA., Bertelsen CV; Cell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark., Gerstenberg MK; GOLD In Vivo Pharmacology DK I, Novo Nordisk, 2760 Måløv, Denmark., Hansen AMK; In Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark., Guldbrandt M; In Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark., Lykkesfeldt J; Section for Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark., John LM; GOLD In Vivo Pharmacology DK I, Novo Nordisk, 2760 Måløv, Denmark., Villaescusa JC; Cell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark., Petersen N; In Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Mar 17; Vol. 23 (6). Date of Electronic Publication: 2022 Mar 17.

Publisher Correction: Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment.

Autor: Kumar P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. parvin.kumar@ki.se.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. parvin.kumar@ki.se., Efstathopoulos P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Millischer V; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Olsson E; Department of Adult Psychiatry, PRIMA Child and Adult Psychiatry AB, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Wei YB; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.; Department of Psychiatry, University of California San Diego, California, USA., Brüstle O; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty, Bonn, Germany., Schalling M; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Villaescusa JC; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Ösby U; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.; Department of Adult Psychiatry, PRIMA Child and Adult Psychiatry AB, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden., Lavebratt C; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Catharina.lavebratt@ki.se.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. Catharina.lavebratt@ki.se.

Publikováno v: Scientific reports [Sci Rep] 2019 Nov 05; Vol. 9 (1), pp. 16377. Date of Electronic Publication: 2019 Nov 05.